Clarity Pharmaceuticals
Sydney
About Clarity Pharmaceuticals
Clarity is a personalized medicine company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally. Clarity’s platform technology allows antibodies to be radiolabeled and visualized using PET imaging. The human imaging data generated provides information on whether the drug reaches the desired disease target in a patient. This information enables a personalized approach to therapy by only treating those patients that are likely to respond to therapy and excluding those that won’t respond to therapy. This precision medicine approach is at the forefront of drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $142.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: asx:CU6
- Website: claritypharmaceuticals.com
- Phone: +610292094037
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/clarity-pharmaceuticals-9645 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.